THERAPEUTIC CLASS
Nebulised N-Acetylcysteine for Unresponsive Bronchial Obstruction in Allergic Brochopulmonary Aspergillosis: A Case Series and Review of the Literature
Many chronic lung diseases are characterized by the hypersecretion of mucus. In these conditions, the administration of mucoactive agents is often indicated as adjuvant therapy. N-acetylcysteine (NAC) is a typical example of amucolytic agent. A retrospective review of patients with pulmonary aspergillosis treated at the National Aspergillosis Centre in Manchester,United Kingdom,with NAC between November. 2015 and November 2017 was carried out. Six Caucasians with Aspergillus lung disease received NAC
to facilitate clearance of their viscid bronchial mucus secretions
No other version available